SEC Form 5 · accession 0001213900-15-000598
TIANYIN PHARMACEUTICAL CO., INC. · TPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bo Tan
Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 30, 2015 · 9:33 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362718
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 4, 2012, Mr. Bo Tan was appointed by the Board of Tianyin Pharmaceutical Co., Inc. (the "Company") as an Independent Director and Chairman of the Company's Audit, Compensation and Nominating Committees. On January 23, 2015, Mr. Tan tendered his resignation from all positions with the Company; on the same day, the Board approved and accepted his resignation, effective immediately.